Certain immune-suppressing therapies reduce vaccine response in subset of multiple sclerosis patients | Ohio State Medical Center
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis | Journal of Neurology, Neurosurgery & Psychiatry
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies - Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, Mark Dolev,
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic | Journal of Neurology, Neurosurgery & Psychiatry
Vaccines | Free Full-Text | Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
Factsheet: COVID-19 Vaccine Guidance for People Living with Multiple Sclerosis (English, Spanish) | Vaccine Resource Hub
MS Patients on Anti-CD20 Therapy May Benefit from COVID Booster
Frontiers | Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study
COVID-19, Vaccinations & Multiple Sclerosis - Practical Neurology
Vaccines | Free Full-Text | Neurological Disorders following COVID-19 Vaccination
Queen Mary University of London
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosis - eBioMedicine
Multiple Sclerosis Patients Show T-Cell Response to COVID-19 Vaccines
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients - ScienceDirect
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point | Neurology and Therapy
COVID-19, Vaccinations & Multiple Sclerosis - Practical Neurology
Frontiers | Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland
Vaccination and immunotherapies in neuroimmunological diseases | Nature Reviews Neurology
COVID-19 vaccination guidance for persons with Multiple Sclerosis (MS) | Multiple Sclerosis Society of NZMultiple Sclerosis Society of NZ
T-cell response to Omicron after an mRNA COVID vaccine booster
The ME Association: Covid Autumn Booster Vaccine Information (2023) - The ME Association
Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry - Multiple Sclerosis and Related Disorders
Vaccines | Free Full-Text | Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations
Vaccines | Free Full-Text | Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis
Vaccines | Free Full-Text | Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study - The Lancet Regional Health – Europe
